Drug Profile
Aciclovir transdermal - Transport Pharmaceuticals
Alternative Names: SoloVirLatest Information Update: 02 Oct 2021
Price :
$50
*
At a glance
- Originator Transport Pharmaceuticals
- Class Antivirals; Eye disorder therapies; Hypoxanthines; Small molecules
- Mechanism of Action DNA-directed DNA polymerase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Herpes simplex virus infections
Most Recent Events
- 31 May 2012 Discontinued - Phase-III for Herpes simplex virus infections in USA (Transdermal)
- 28 Nov 2007 Efficacy and safety data from a phase II trial (TPI-H-221) in recurrent herpes labialis released by Transport Pharmaceuticals
- 01 May 2007 Transport Pharmaceuticals initiates dosing in a phase II trial (TPI-H-221) for recurrent herpes labialis in the US